Alert Context

Health systems are facing tighter allocation of neuro sponges, also known as neuropatties, and neuro strips. Here, we explain the reasons behind the surge in demand and how procurement teams can address the challenge.

Supply Gap Analysis

Product constraints are concentrated across Medline's NEUROSPNG product family and are cascading into branded neuro convenience kits.

Medline issued a voluntary recall covering all lots of its X-ray-detectable neuro sponge codes manufactured on or after March 1, 2021, citing higher-than-expected endotoxin levels identified during an internal quality review.

Because endotoxin is heat-stable and not addressed by terminal sterilization, remediation requires reworking upstream bioburden controls rather than reprocessing existing inventory.

Affected sponges were components in multiple Medline neuro convenience trays, including NEUROSPNG02, NEUROSPNG05, NEUROSPNG06, NEUROSPNG07, NEUROSPNG09, NEUROSPNG11, NEUROSPNG13, and NEUROSPNG14.

Market dynamics exacerbated the situation as the secondary supplier base had already thinned ahead of this event, with several manufacturers exiting the neuro sponge category over the past 24 months due to margin compression on commodity surgical textiles.

Concurrent capacity constraints at Integra, including Codman patties and strips, and tight medical-grade rayon lead times have left remaining suppliers such as DeRoyal, American Surgical, Medicom AMD-Ritmed, Pilling Weck, Stevens, and SDP operating under protective allocation and largely closed to net-new accounts.

What Health Systems Can Do Now

Secondary channels have access to product buckets that are usually unavailable under centralized contract models that prioritize a single supplier.

Developing relationships with alternative suppliers for critical categories that can disrupt patient care and interrupt clinical operations is fundamental.

Map categories based on clinical criticality and market dynamics, while prioritizing reliable partners focused on overcoming supply disruptions. A small purchase order can be used as a trial to evaluate a supplier's fulfillment capacity.

Cato is actively sourcing and translating Medline NEUROSPNG sizes to functional equivalents, such as DeRoyal 30-series products.

For facilities locked out of secondary suppliers, Cato works with distributors and direct channels to find available lots across diverse regional inventory pools, giving facilities nationwide more options.

If neuro sponges or affected kits are showing up on a shortage list, send the SKUs and weekly case volumes, and Cato will run a real-time availability check against current supplier positions.

Our Risk Radar technology provides a live view of impacted categories across the medical supply chain.

• Map affected neuro sponge SKUs and convenience trays to understand recall and allocation exposure.
• Use alternative suppliers and secondary channels for categories that can disrupt patient care.
• Trial small purchase orders with reliable partners to confirm fulfillment capacity before a shortage escalates.